trending Market Intelligence /marketintelligence/en/news-insights/trending/vh5Ypd-LnJlMt77l8Q7AfA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Spark Therapeutics starts common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Spark Therapeutics starts common stock offering

Spark Therapeutics Inc. initiated an underwritten public offering of $300 million of its common stock.

The company also intends to grant the underwriters an option to buy up to an additional 15% of the shares offered.

J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Co. LLC will act as book-running managers for the offering.